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A BST R AC T   
 
Aim: Research into the different treatment methods based on the intrauterine lipopolysaccharide 
(LPS)-induced periventricular leukomalacia (PVL) model, as one of the main causes of morbidity in 
preterm infants still continues to be relevant. The present study investigates the effect on PVL of 
salidroside obtained from Rhodiola Rosea (golden root, orpin rose), which is a plant with known for 
its medicinal qualities.   
Method: To develop an induced PVL model, a 500 microgram/kg dose of LPS (Escherichia coli, 
serotype 055:B5, Sigma) was applied to two pregnant rats intraperitoneally on day 18, day 19 and 
day 20 of gestation. One of the LPS applied rats was given 25 mg/kg salidroside (250 mg Rhodiola 
root extract capsules, which include 3 mg salidroside) by oral gavage (LPS+Salidroside), and a 
physiological saline solution was given to the control group.  
After delivery, 10 offspring of the LPS-applied mother, nine offspring of the LPS+Salidroside-
applied mother and seven offspring of the control mother were sacrificed on postnatal day 7 with 
ether anesthesia. The caspase enzyme located in apoptosis pathways of 10 percent neutral-buffered 
formalin fixed brain tissue was stained immunohistochemically, and apoptotic cells were counted.  
Results: No statistically significant difference was noted between the LPS+Salidroside group and the 
control group, while a statistically significant difference was noted between the LPS and 
LPS+Salidroside groups. It was observed that salidroside reduced LPS induced apoptosis.  
Conclusion: The intended experimental neuroprotective effect of salidroside usage was provided 
through the inhibition of apoptosis in a PVL-damaged brain.  
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Introduction 
Periventricular leukomalacia (PVL) is a 
significant cause of morbidity in preterm 
infants. Hypomyelination develops because of 
a failure of the myelin-forming mature 
oligodendrocytes as a result of precursor 
oligodendrocyte cell damage in PVL, which 
caused cystic lesions in white matter or diffuse 
involvement. The predisposing factors for 
PVL are hypoxia, ischemia and inflammation 
[1-3].   
The medicinal properties of Rhodiola Rosea 
(golden root, orpin rose) have been known for 
centuries. It induces neurotransmitter activity 
(e.g. serotonin, dopamine, norepinephrine), 
and also has inflammatory and antioxidant 
characteristics. It has been reported to reduce 
inflammation in LPS-induced microglial cell 
damage, and so can be used for the treatment 
of neurodegenerative diseases [4]. The active 
component in the plant is salidroside.  
The effect of salidroside on an intrauterine 
lipopolysaccharide (LPS) administration-
induced Periventricular leukomalacia (PVL) 
model, as a major cause of morbidity in 
preterm infants, was investigated. 
 
Methods 
This study was approved by the AIBU Animal 
Research Local Ethics Committee and carried 
out in the AIBU Experimental Animals 
Application and Research Center and AIBU 
Faculty of Science and Literature Alper 
Karakaş Laboratory. Female Wistar rats were 
fed standard pellets and water and kept in 
standard cages at room temperature at 50–60 
percent humidity in a 12 hour light/dark cycle. 
Three selected female mature rats in their 
estrous cycle, ascertained through a vaginal 
smear, were mated, and the mating day was 
accepted as day 0 of pregnancy. To develop an 
induced PVL model, a 500 microgram/kg dose 
of intraperitoneal LPS (Escherichia coli, 
serotype 055:B5, Sigma) was applied to two 
pregnant rats on days 18, 19 and 20 of 
gestation. Of the LPS-applied rats, one was 
given 25 mg/kg salidroside (250 mg Rhodiola 
root extract capsules, containing 3 mg 
salidroside) by oral gavage (LPS+Salidroside), 
and a physiological saline solution was given 
to the control group.  
After delivery, 10 offspring of the LPS-applied 
mother, nine offspring of the LPS+Salidroside-
applied mother and seven offspring of the 
control mother were terminated under ether 
anesthesia by brain fixation using 4 percent 
paraformaldehyde via a transcardiac perfusion 
on postnatal day 7. The caspase enzyme 
located in the apoptosis pathways of the 10 
percent neutral-buffered formalin fixed brain 
tissue was stained immunohistochemically. 
All sections (at least four sections for each 
tissue) were analyzed and those with artefacts 
apparent only due to staining, were excluded 
from assessment. Apoptotic cells with positive 
stained active caspase-3 immunoreactivity 
were counted, and the mean apoptotic cell 
number was determined for each brain. All 
groups were compared with a Mann–Whitney 
U-test using a PASW Statistics 18 program. 
 
Results 
After delivery, 10 offspring of the LPS-applied 
mother,   9 offspring  of  the  LPS+Salidroside 
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applied mother and seven offspring of the 
control mother were included in the study.  
No statistically significant difference was 
identified between the LPS+Salidroside group 
and the control group, while a statistically 
significant difference was determined between 
the LPS and LPS+Salidroside groups. It was 
observed that salidroside reduced LPS-induced 
apoptosis (Figure 1). The histopathological 
study of apoptotic cells is given in Figure 2. 
 





Figure 2. Representative light-microscopic 
images of anti-caspase-3 




The predisposing factors for PVL are hypoxia, 
ischemia and inflammation, while other 
possible mechanisms are microglial activation 
and axonal degeneration [1-3].  There are 
many factors that play a fundamental role in 
PVL pathogenesis, which include hypoxia, 
ischemia, both reactive oxygen (ROS) and 
nitrogen (RNS) free radical damage, and 
glutamate excitotoxicity. Myelination 
deficiencies related to the microglial activation 
and the loss of precursor oligodendrocytes 
were observed [5]. 
Hydroxyl radicals (OH–), which are 
responsible for tissue damage, occur in two 
main ways in free radical damage, being 
formed by reactive oxygen species or by 
reactive nitrogen species. The pre-requirement 
for this is oxygen interacting with free 
electrons, and the formation of hydrogen 
peroxide and superoxide. Oxygen interacts 
with a free electron through the hypoxanthine-
xanthine oxidase-xanthine system in the 
reperfusion/reoxygenation phase after 
ischemia/hypoxia. Xanthine oxidase is an 
important source of free radicals, and it has 
been shown that Rhodiola Rosea inhibits 
xanthine oxidase enzyme activity [6]. In the 
same study, it was found that it also reduces 
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oxidant enzyme activities such as lipoxygenase 
and tyrosinase. Salidroside, the active 
substance in Rhodiola Rosea, has also shown 
neuronal cell protective effects to glucose and 
serum-restriction in cell cultures [7]. 
Salidroside has also been reported to have 
neuroprotective effects in cases of glutamate-
induced neuronal damage [8]. Salidroside has 
the potential to have a protective effect both on 
the reduction of oxidant and lytic enzyme 
activity and brain damage resulting from such 
excitotoxic agents as glutamate.  
Salidroside causes the formation of 
dopaminergic neurons in mesenchymal stem 
cells, which increases the synthesis of such 
factors involved in neuronal development as 
BDNF, NGF and neurotrophin-3 [9]. It has 
been reported that antenatal neurotrophin 
exposure reduces hypomyelination in LPS-
induced damage and has a protective effect 
against apoptosis [10].  Other studies have 
found that in the LPS-induced acute lung 
injury model in mice reduces the number of 
macrophages and neutrophils in broncho 
alveolar lavage and suppresses the production 
of such important inflammatory cytokines as 
TNF-α, IL-6, IL-1β and NF-κB DNA-binding 
activation [11]. Intraperitoneal or intracervical 
injections of LPS into rats causes intrauterine 
inflammation, which leads to cytokine 
stimulation in the fetus and the neonatal brain, 
and results in white matter damage similar to 
PVL. Maternal LPS injections can have 
significant effects on myelination and 
astrogliosis in neonatal rat brains [12-14].  İn 
the present study, its apoptosis-reducing 
effects and its effects in the LPS-induced PVL 
model have been observed. In other words, the 
intended experimental neuroprotective effect 
of Salidroside usage was provided with the 
inhibition of apoptosis in a PVL-damaged 
brain.  
The antioxidant and anti-inflammatory 
features of salidroside mean that it may be 
neuroprotectant in PVL.  It can also be 
suggested that positive results may be obtained 
by increasing the neuronal plasticity effect in 
developing brain tissue. Maternal salidroside 
administration may also be effective in 
preventing the intrauterine PVL process, 
although there have been no studies to date 
examining the effects of salidroside on brain 
damage in cases of periventricular 
leukomalacia. If its neuroprotective effects can 
be demonstrated in the periventricular 
leukomalacia process as a result of this study, 
an important step will be taken towards the 
prevention of periventricular leukomalacia, 
which is one of the most significant problems 
in premature babies.  
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